InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Cash from Investing Activities came in at -$1.3 million in Q1 2026, up 52.65% YoY from -$825421.0 in Q1 2025, and up 42.52% on a QoQ basis from -$2.2 million in Q4 2025.
InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Cash from Investing Activities data on file, last reported at -$1.3 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 52.65% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 65.19% YoY) and the FY2025 annual result came in at -$6.8 million, up 48.71% from the prior year.
- Cash from Investing Activities improved to -$1.3 million in Q1 2026, from -$2.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$252000.0 in Q3 2025 to a low of -$6.7 million in Q2 2024.
- A 5-year average of -$2.3 million and a median of -$2.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 91.43% — and 2024, when it slumped 852.0%.
- Tracing INFU's Cash from Investing Activities over 5 years: stood at -$3.1 million in 2022, then surged by 65.79% to -$1.0 million in 2023, then tumbled by 213.12% to -$3.3 million in 2024, then surged by 32.95% to -$2.2 million in 2025, then jumped by 42.52% to -$1.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$1.3 million (Q1 2026), -$2.2 million (Q4 2025), and -$252000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | -4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.52 Mn |
| Jun 30, 2026 | -4.52 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -252,000.00 |
| Sep 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -1.69 Mn |
| Jun 30, 2025 | -1.69 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | -3.27 Mn |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Mar 31, 2024 | -418,000.00 |
| Mar 31, 2024 | -418,000.00 |